Skip to main content

Table 4 Outcome data

From: Prehospital administration of tranexamic acid in trauma patients

  Tranexamic acid (TXA) group Control group p Value
ICU LOS, days, mean ± SD (n) 10.7 ± 12.6 (258) 9.2 ± 11.4 (258) 0.03
Hospital LOS, days, mean ± SD (n) 25.5 ± 23.2 (258) 22.3 ± 25.4 (258) 0.04
Thromboembolic event, n (%) 4/71 (5.6) 10/121 (8.3) 0.58
Sepsis, n (%) 4/67 (6.0) 8/119 (6.7) 1.00
Multiple organ failure, n (%) 27/74 (36.5) 35/121 (28.9) 0.34
Time to death, days, mean ± SD (n) 8.8 ± 13.4 (258) 3.6 ± 4.9 (258) 0.001
6-h mortality, n (%) 5/258 (1.9) 24/258 (9.3) <0.001
12-h mortality, n (%) 9/258 (3.5) 28/258 (10.9) 0.002
24-h mortality, n (%) 15/258 (5.8) 32/258 (12.4) 0.01
30-day mortality, n (%) 36/258 (14.0) 42/258 (16.3) 0.54
In-hospital mortality overall, n (%) 38/258 (14.7) 42/258 (16.3) 0.72
Mortality prognosis in %, based on RISC 2 score (n) 15.4 % (258) 15.2 % (258) 0.38
  1. ICU intensive care unit, LOS length of stay, RISC Revised Injury Severity Classification, SD standard deviation
  2. As some values were missing, the respective population is documented in brackets for continuous variables and in the denominator for categorical variables